AnnJi Pharmaceutical Co., Ltd. (AnnJi, TWSE: 7754) announced that the Phase 2a clinical result of AJ201 for spinal and bulbar ...

Roche has moved the Supreme Court challenging a Delhi HC order that allowed Natco Pharma to manufacture and sell a generic ...

The Delhi High Court on Thursday upheld a single judge's refusal of an interim injunction sought by Swiss pharmaceutical ...

F. Hoffmann-La Roche AG has approached the Supreme Court. This follows a Delhi High Court decision permitting Natco Pharma to ...

Roche approached the Supreme Court after the Delhi High Court division bench refused to bar Natco Pharma from selling the ...

Swiss pharmaceutical giant F Hoffmann-La Roche AG has approached the Supreme Court against the Delhi High Court's order allowing Natco Pharma to manufacture and sell a generic drug of Risdiplam, ...

NATCO Pharma has won a landmark legal battle to launch a generic version of Risdiplam, a drug for Spinal Muscular Atrophy ...

The drug belantamab mafodotin – also known as Blenrep – has been approved for use for patients with myeloma, when used ...

Shares in US biopharma Scholar Rock closed 13% lower Monday after bad news on its spinal muscular atrophy (SMA) treatment ...

In what is being termed a major victory, Natco Pharma has won a legal battle against Swiss pharma giant Roche, allowing the ...

In a closely watched case, Roche suffered a setback as a court said it would permit a generic version of its rare disease ...